InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by BAKEWELL JOHN K, Director. Officer active across 3 companies, notably Neuronetics, Inc.. In total, 6 filings have been published. The latest transaction was disclosed on 17 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
38,910 shares
Common Stock
SEC:0001062993-22-013871:0·
02,295 shares0
Common Stock
SEC:0001567619-22-011340:0·
085,337 shares0
Common Stock, $0.000001 par value
SEC:0001235802-21-000107·
085,337 shares0
Common Stock, $0.000001 par value
SEC:0001235802-21-000107:0·
7,137 shares
Common Stock
SEC:0001062993-21-005247·
7,137 shares
Common Stock
SEC:0001062993-21-005247:0·
6 of 6 declarations
About BAKEWELL JOHN K
John K. Bakewell is a Board Member at Neuronetics, Inc., Xtant Medical Holdings, Inc., and Treace Medical Concepts, Inc. He contributes to the strategic direction of these companies, bringing his expertise in management and finance. His role on the board allows him to participate in important decision-making for the development and sustainability of these companies, ensuring they meet their financial objectives.
